Encouraging News for the Treatment of Ewing Sarcoma
Researchers at Georgetown University Medical Center have found in preclinical rat studies that the agent (S)-YK-4-279, developed by Dr. Jeffrey Toretsky, halted the progression of ... Read More


Development of Specialty Drugs to Increase
A recent report by Express Scripts shows the wave of the future may be in specialty drugs.  With between 600 and 1,000 specialty drugs in ... Read More


Hormone May Reverse Symptoms of Heart Failure
Reverse the signs of cardiac aging, wouldn't that be nice?  Well researchers at the Harvard Stem Cell Institute have done just that.  In a recent ... Read More


2012 Top 10 Pharmaceutical Companies (based on revenue)
With many patents expiring in 2012, it is easy to understand how some companies saw dramatic drops in revenue.  That said many saw little to ... Read More


AbbVie’s First Quarter
Despite problems with their lipid franchise, the newly formed AbbVie had better than expected first quarter results due to strong sales of their rheumatoid arthritis ... Read More


Alcon Receives FDA Approval for Combination Therapy to Fight Glaucoma
The exact source of one of the leading causes of preventable blindness in not known; however, Alcon, the global leader in eye care, has taken ... Read More


Gliead, Bristol-Myers Squibb, AbbVie & Hepatitis C
There is good news on the horizon for patients battling Hepatitis C as recent results from Phase II and Phase III studies show promising results ... Read More


Bristol-Myers Squibb to Expand
Bristol-Myers Squibb has announced that it will invest in a 200,000 square foot expansion to its Devens, MA site. Construction is due to start in ... Read More


Pfizer Plans a Move to Kendall Square
Pfizer plans to move most of its Boston R& D employees from Cambridge to Kendall Square in 2014.  The reason for the move is it ... Read More


Breast Cancer Treatment without Chemotherapy
Researchers have found that patients with a certain type of breast cancer have responded to a form of targeted treatment that uses a combination of ... Read More


« prev - page 1 of 2 - next »